KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Enterobacter aerogenes (North America + ceftazidime-resistant)

• Enterobacter aerogenes
• Enterobacter aerogenes (3701 + β-lactamase positive)
• Enterobacter aerogenes (41)
• Enterobacter aerogenes (41003)
• Enterobacter aerogenes (ampicillin-resistant + cefazolin-resistant)
• Enterobacter aerogenes (ATCC 13048)
• Enterobacter aerogenes (ATCC 29751)
• Enterobacter aerogenes (B1 + amp(C))
• Enterobacter aerogenes (ceftazidime-resistant)
• Enterobacter aerogenes (CIP 6069)
• Enterobacter aerogenes (CMCC(B) 45103)
• Enterobacter aerogenes (EA27)
• Enterobacter aerogenes (EA289)
• Enterobacter aerogenes (EA294)
• Enterobacter aerogenes (EA298)
• Enterobacter aerogenes (EA3)
• Enterobacter aerogenes (EA5)
• Enterobacter aerogenes (EA-CM64)
• Enterobacter aerogenes (ESBL)
• Enterobacter aerogenes (Europe + ceftazidime-resistant)
• Enterobacter aerogenes (Europe)
• Enterobacter aerogenes (KCTC 2190)
• Enterobacter aerogenes (KTCC 2190)
• Enterobacter aerogenes (NCIM 5139)
• Enterobacter aerogenes (NCTC 10006 + Greece)
• Enterobacter aerogenes (NCTC 10006)
• Enterobacter aerogenes (NCTC 9343)
• Enterobacter aerogenes (North America + ceftazidime-resistant)
• Enterobacter aerogenes (North America)
• Enterobacter aerogenes (TP)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8